Evommune, Inc. (EVMN) Institutional Ownership & Insider Trading
105 institutions reported holding Evommune, Inc. shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 16 insider trades on Form 4 since 2025-10-01.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
EVMNEvommune, Inc.Follow EVMN — free
—
Price chart with a free account
- Market cap
- 185.1M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 9 Dec, in 46 days
Institutions · all 13F filers
quarter to 30 Jun 2026 · filers in both quarters105 institutions held 95.4% of the shares. Across filers that reported both quarters, shares held changed +4.1%.
Largest moves, shares (millions)
Institutional flow by quarter
net shares added or trimmed, millions · filers in both quarters| Quarter | Holders | Shares held, M | Change | Increased | New | Decreased | Closed |
|---|---|---|---|---|---|---|---|
| Jun 26 | 105 | 35 | +4.1% | 36 | 40 | 13 | 15 |
| Mar 26 | 84 | 35 | +26.9% | 26 | 31 | 11 | 10 |
| Dec 25 | 59 | 27 | — | — | — | — | — |
Evommune, Inc. — questions
- Who owns Evommune, Inc. stock?
- 105 institutions reported Evommune, Inc. shares in 13F filings for the quarter ended 2026-06-30. The largest: EQT Fund Management S.a r.l. (14.6%), RA CAPITAL MANAGEMENT, L.P. (9.6%), PRICE T ROWE ASSOCIATES INC /MD/ (5.3%).
- Are Evommune, Inc. insiders buying or selling?
- 16 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.
Every figure on this page comes from Evommune, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.